The pharma company has entered into a Settlement Agreement with Forest Laboratories Forest Laboratories Holdings and Royalty Pharma Collection Trust to settle and dismiss the outstanding patent litigation related to Glenmarkâs Abbreviated New Drug Application for Milnacipran Hydrochloride.
| Subscribe To Our Free Newsletter |
